Showing results (501-510 of 605) with videos related to
Sort By:
Pageof 61
Pediatrics|September 1, 1990
Characteristics of eighth-grade students who initiate self-care in elementary and junior high schoolK M Dwyer, J L Richardson, K L Danley, et al.Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairmentC E Halstenson, M O Wong, C A Johnson, et al.Preventive Medicine|January 1, 1995
The television, school, and family smoking prevention and cessation project. VIII. Student outcomes and mediating variablesB R Flay, T Q Miller, D Hedeker, et al.Experimental Neurology|October 1, 1993
Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortexA S Fix, J W Horn, K A Wightman, et al.Journal of Applied Microbiology|August 18, 2012
Test method development to evaluate hot, humid air decontamination of materials contaminated with Bacillus anthracis ∆Sterne and B. thuringiensis Al Hakam sporesT L Buhr, A A Young, Z A Minter, et al.Pediatrics|January 31, 1998
Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter studyM T Britto, J M Garrett, M A Dugliss, et al.Family Medicine|May 1, 1992
Teaching family-centered perinatal care in family medicine, Part IJ E Scherger, C Levitt, L S Acheson, et al.Family Medicine|July 1, 1992
Teaching family-centered perinatal care in family medicine, Part 2J E Scherger, C Levitt, L S Acheson, et al.The European Respiratory Journal|June 1, 1995
Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatmentP I Shah, A Bush, G J Canny, et al.Prostaglandins & Other Lipid Mediators|February 17, 1999
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseasesJ B Travers, R C Murphy, C A Johnson, et al.Pageof 61